FDA NDC Directory · JSON-LD · Markdown

EPYSQLI

NDC 51759-208 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameEculizumab-aagh
Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryBiologic License Application · App BLA761340
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsECULIZUMAB (300 mg/30mL)
Marketing started20250407
Package count1

External sources

Source: openFDA. Public-domain (CC0).